No products in the cart.
We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.
The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ...
Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.
Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.
Upon completion of this activity, participants will: Recognize the long-term burden of uncontrolled asthma Analyze the efficacy of biologics in reducing asthma exacerbations in patients with moderate to severe asthma Evaluate the relationship between asthma phenotypes and disease severity to guide personalized treatment recommendations Assess asthma severity to support appropriate referral Identify patients who could benefit from biologic therapy for moderate to severe asthma.
In this series of bite-sized video chapters, experts provide insight on strategies and advances in the management of severe asthma.
CME Disclosure: https://www.medscape.org/viewarticle/1002392
All Credits Available
Physicians
Maximum of 0.50 AMA PRA Category 1 Credit(s)™
Nurses
0.50 ANCC Contact Hour(s) (0 contact hours are in the area of pharmacology)
IPCE
0.50 Interprofessional Continuing Education (IPCE) credit
CME / CE Released: 3/26/2025
Valid for credit through: 3/26/2026, 11:59 PM EST
| Contributor | Sabah F. Iqbal, MD; Monica Kraft, MD; Charles Vega, MD |
|---|---|
| Date Content Reviewed | April 2025 |
| Future Review Date | March 2026 |
| Format | Activity |
| Length | 1 hour |
| Publication Date | 3/31/2025 |
| Source | Medscape |
Notifications
